Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,255 | 931 | 99.0% |
| Travel and Lodging | $145.85 | 1 | 0.8% |
| Education | $41.29 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $4,295 | 210 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,517 | 86 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,130 | 71 | $0 (2024) |
| ABBVIE INC. | $982.90 | 62 | $0 (2023) |
| Lilly USA, LLC | $733.93 | 54 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $675.08 | 15 | $0 (2021) |
| Merck Sharp & Dohme LLC | $643.71 | 57 | $0 (2024) |
| Amarin Pharma Inc. | $485.43 | 30 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $456.44 | 35 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $426.93 | 30 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,191 | 85 | Novo Nordisk Inc ($483.36) |
| 2023 | $2,057 | 104 | Novo Nordisk Inc ($390.90) |
| 2022 | $2,105 | 104 | Novo Nordisk Inc ($622.23) |
| 2021 | $2,544 | 100 | Biohaven Pharmaceuticals, Inc. ($607.14) |
| 2020 | $666.99 | 45 | AstraZeneca Pharmaceuticals LP ($136.19) |
| 2019 | $2,951 | 137 | AstraZeneca Pharmaceuticals LP ($1,003) |
| 2018 | $3,125 | 172 | Novo Nordisk Inc ($852.64) |
| 2017 | $2,802 | 192 | Novo Nordisk Inc ($753.98) |
All Payment Transactions
939 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: VACCINE | ||||||
| 11/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.31 | General |
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $26.59 | General |
| 10/28/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: PAIN | ||||||
| 10/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: PAIN | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Stryker Corporation | INSIGNIA (Device), MAKO | Food and Beverage | In-kind items and services | $149.30 | General |
| Category: JOINT REPLACEMENT HIPS, KNEES | ||||||
| 09/10/2024 | Stryker Corporation | INSIGNIA (Device) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: JOINT REPLACEMENT HIPS, KNEES | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Endocrinology | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: VACCINE | ||||||
| 08/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/21/2024 | Inari Medical, Inc. | CT THROMBECTOMY SYSTEM KIT (Device), FLOWTRIEVER CATHETER, S | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: VTE | ||||||
| 08/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 586 | 763 | $202,539 | $55,837 |
| 2022 | 15 | 589 | 875 | $176,485 | $52,366 |
| 2021 | 13 | 586 | 769 | $154,586 | $49,744 |
| 2020 | 12 | 460 | 639 | $119,907 | $39,384 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 286 | $96,447 | $22,639 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 117 | 117 | $41,517 | $14,459 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 157 | $37,662 | $8,428 | 22.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $12,020 | $4,512 | 37.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $6,664 | $2,693 | 40.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 18 | 18 | $1,742 | $962.76 | 55.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 60 | $1,512 | $562.98 | 37.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $2,042 | $495.90 | 24.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $703.49 | $353.19 | 50.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $771.00 | $263.85 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $753.00 | $219.60 | 29.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 13 | 13 | $602.00 | $210.60 | 35.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 17 | $104.00 | $37.40 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 147 | 248 | $77,181 | $19,446 | 25.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 118 | 118 | $37,899 | $15,174 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 179 | $39,719 | $9,525 | 24.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $6,150 | $2,445 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 23 | 23 | $3,772 | $1,576 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $2,117 | $823.02 | 38.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 74 | $2,647 | $781.88 | 29.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 17 | 18 | $2,034 | $760.52 | 37.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 46 | 69 | $1,713 | $642.62 | 37.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $798.00 | $401.67 | 50.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $1,006 | $390.88 | 38.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 11 | 11 | $495.00 | $199.16 | 40.2% |
About Dr. John Moon, M.D
Dr. John Moon, M.D is a Family Medicine healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417912833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Moon, M.D has received a total of $18,442 in payments from pharmaceutical and medical device companies, with $2,191 received in 2024. These payments were reported across 939 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($18,255).
As a Medicare-enrolled provider, Moon has provided services to 2,221 Medicare beneficiaries, totaling 3,046 services with total Medicare billing of $197,331. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Plano, TX
- Active Since 04/19/2006
- Last Updated 07/22/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1417912833
Products in Payments
- FARXIGA (Drug) $1,681
- NURTEC ODT (Drug) $1,268
- Ozempic (Drug) $1,194
- Tresiba (Drug) $570.91
- Victoza (Drug) $566.35
- Vascepa (Drug) $485.43
- Rybelsus (Drug) $411.69
- Azstarys (Drug) $360.85
- UBRELVY (Drug) $350.41
- JANUVIA (Drug) $339.20
- JARDIANCE (Drug) $331.18
- SHINGRIX (Biological) $326.25
- XARELTO (Drug) $298.15
- MOUNJARO (Drug) $280.80
- SYMBICORT (Drug) $260.77
- BREO (Drug) $256.15
- TOUJEO (Drug) $250.29
- RYBELSUS (Drug) $242.52
- Myrbetriq (Drug) $242.03
- GEMTESA (Drug) $221.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Plano
Dr. Mahdi Awwad, M.d, M.D
Family Medicine — Payments: $24,534
Elaine Timm, Md, MD
Family Medicine — Payments: $19,841
Mr. Jose Trevino, Md, MD
Family Medicine — Payments: $18,709
Dr. Yan Li, M.d., Ph.d, M.D., PH.D
Family Medicine — Payments: $17,814
Abel Garduno, M.d, M.D
Family Medicine — Payments: $17,192
Dr. Todd Wien, Md, MD
Family Medicine — Payments: $13,547